EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Propofol versus Ketamine in rapid sequence intubation in critically ill patients: a prospective, randomized, controlled trial

Raysa Cristina Schmidt, Fernando Godinho Zampieri, Fernando Jose da Silva Ramos, Felipe Santos Cavatoni Serra, Bruno Adler Maccagnan Pinheiro Besen, Nathaly Fonseca Nunes, Daniela Boschetti, Fernanda Chohfi Atallah, Miriam Jackiu, Livia Maria Garcia Melro, Carla Daniele Nascimento Pontes, Daniere Yurie Vieira Tomotani und 4 weitere

Intensive Care Medicine · 2026-03 · 52 (3) · 476-489

DOI: 10.1007/s00134-026-08351-3 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Intensive Care Medicine, online erschienen am 23.03.2026. Verfasst von Raysa Cristina Schmidt und 15 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Department, Hospital São Paulo, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Ketamine, Propofol, Rapid Sequence Induction and Intubation, Hypnotics and Sedatives. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Cristália.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The optimal hypnotic agent for rapid sequence intubation (RSI) in critically ill patients remains uncertain. We evaluated whether Ketamine is a better alternative than propofol. METHODS: In this investigator-initiated, randomized, controlled, open-label trial conducted in two mixed ICU, adults (≥ 18 years) requiring RSI were assigned 1:1 to Ketamine or propofol. The primary outcome was the lowest mean arterial pressure (MAP) within the first 10 min after induction, analyzed with a linear regression model adjusted for age, baseline MAP, and total vasopressor dose within 10 min. RESULTS: From October 2021 to October 2023, 207 patients were randomized and 175 were included in the modified intention-to-treat analysis. The lowest MAP within 10 min was 66 (55-79) mmHg with Ketamine and 60 (48-72) mmHg with propofol (mean difference, 6.0 [95% CI - 0.0 to 11.9]; p = 0.050). The average MAP difference over the first hour was 1.67 (95% CI - 1.98 to 5.31). Cardiovascular collapse occurred in 20/91(22%) Ketamine-treated patients and 28/84 (33%) receiving propofol, mainly due to an increase in the vasopressor dose within 2 min. Day-7 mortality was 33% with Ketamine and 23.8% with propofol (OR 1.38; 95% CI 0.86-2.24). Hospital mortality was 60.4% and 50.0%, respectively (OR 1.21; 95% CI 0.92-1.58). CONCLUSIONS: Among critically ill patients undergoing RSI, Ketamine resulted in a less pronounced decrease in MAP in the first 10 min compared with propofol, but the difference was not clinically meaningful or sustained. These findings challenge sedative selection based solely on perceived risk of hypotension and highlight the need for larger trials to determine the optimal induction agent. GOV REGISTRY: NCT05092152-initial release 10.13.2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetaminePropofolRapid Sequence Induction and IntubationHypnotics and SedativesHumansCritical IllnessFemaleMiddle AgedProspective StudiesMaleAgedIntensive Care UnitsArterial Pressure

Stichwörter der Autor:innen

Airway managementHypnoticsIntubationKetaminePropofolRapid sequence intubation

Substanzen

KetaminePropofolHypnotics and Sedatives

Autor:innen und Institutionen

  • Intensive Care Department, Hospital São Paulo, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Programa de Pós-Graduação em Medicina Translacional, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Hospital do Serviço Social da Indústria do Papel, Papelão e Cortiça do Estado de São Paulo (SEPACO), São Paulo, Brazil.
  • Intensive Care Department, Hospital São Paulo, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil. frmachado@unifesp.br.
  • Programa de Pós-Graduação em Medicina Translacional, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil. frmachado@unifesp.br.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Cristália

Zitieren

APA

Schmidt, R. C., Zampieri, F. G., da Silva Ramos, F. J., Santos Cavatoni Serra, F., Maccagnan Pinheiro Besen, B. A., Fonseca Nunes, N., Boschetti, D., Chohfi Atallah, F., Jackiu, M., Garcia Melro, L. M., Nascimento Pontes, C. D., Vieira Tomotani, D. Y., Petri Damiani, L., Rezende de Freitas, F. G., Machado, F. R., & PROMINE Investigators (2026). Propofol versus Ketamine in rapid sequence intubation in critically ill patients: a prospective, randomized, controlled trial. Intensive Care Medicine, 52(3), 476-489. https://doi.org/10.1007/s00134-026-08351-3

Vancouver

Schmidt RC, Zampieri FG, da Silva Ramos FJ, Santos Cavatoni Serra F, Maccagnan Pinheiro Besen BA, Fonseca Nunes N, et al. Propofol versus Ketamine in rapid sequence intubation in critically ill patients: a prospective, randomized, controlled trial. Intensive Care Medicine. 2026;52(3):476-489. doi:10.1007/s00134-026-08351-3

BibTeX
@article{Schmidt2026,
  author = {Schmidt, Raysa Cristina and Zampieri, Fernando Godinho and da Silva Ramos, Fernando Jose and Santos Cavatoni Serra, Felipe and Maccagnan Pinheiro Besen, Bruno Adler and Fonseca Nunes, Nathaly and Boschetti, Daniela and Chohfi Atallah, Fernanda and Jackiu, Miriam and Garcia Melro, Livia Maria and Nascimento Pontes, Carla Daniele and Vieira Tomotani, Daniere Yurie and Petri Damiani, Lucas and Rezende de Freitas, Flávio Geraldo and Machado, Flávia Ribeiro and PROMINE Investigators, PROMINE Investigators},
  title = {Propofol versus Ketamine in rapid sequence intubation in critically ill patients: a prospective, randomized, controlled trial},
  journal = {Intensive Care Medicine},
  year = {2026},
  volume = {52},
  number = {3},
  pages = {476--489},
  doi = {10.1007/s00134-026-08351-3}
}
Kostenlos starten →